Cargando…
Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines
Loss of TP53 and RB1 function have both been linked to poor response to DNA damaging drugs in breast cancer patients. We inactivated TP53 and/or RB1 by siRNA mediated knockdown in breast cancer cell lines varying with respect to ER/PgR and Her-2 status as well as TP53 and RB1 mutation status (MCF-7,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439126/ https://www.ncbi.nlm.nih.gov/pubmed/28580174 http://dx.doi.org/10.1038/cddiscovery.2017.26 |